Musculoskeletal (MSK) injuries place a staggering $380B annual burden on the U.S. healthcare system, affecting tens of millions of people every year. The rise in MSK conditions is simply unsustainable.
The lack of quantifiable metrics leads to high variability in clinical outcomes, making it difficult for clinics to justify reimbursement with objective data. This gap also limits the ability to scale healthcare best practices across therapists, locations, and populations.
Therapy has long relied on feel, despite evidence that measurement and dosing affect outcomes. Manual techniques vary widely among clinicians due to subjective judgment and inconsistent application without standardization.
Research shows that therapy with optimal intensity, frequency, and duration directly influences recovery. Without objective measures during soft tissue therapy, clinicians lack a clear framework for delivering better care.
Lives Impacted by Rehabilitation Need
U.S. Rehab Market Today, Growing to $76B
Projected Growth in Rehab Workforce Demand
Physical Therapy Visits Annually in the U.S.
Manual therapy often relies on subjective interpretation and inconsistent techniques. With Quantitative Soft Tissue Manipulation (QSTM®), PrecisionCare AI is the first solution to measure soft tissue treatment in real-time.
Our PrecisionCare AI patented devices quantify force, pressure, angle, and distance. This provides real-time visibility and data-driven tracking of therapy.
